A study in Nature found a specific genetic variant that may boost the effectiveness of GLP-1 weight-loss drugs like ...

Hello Health Rounds readers. Today we feature a pair of studies that took a deeper dive into the effects of GLP-1 drugs being ...

War in Iran threatens pharma; HHS Secretary Kennedy to launch podcast about health ‘lies;’ CDC holds report showing vaccine ...

A study involving nearly 28,000 people identifies the genes that may influence weight loss with Ozempic and Mounjaro.

A Black teenager in California is suing the City of San Bernardino and two police officers after a violent 2025 arrest left ...

The idea that modern humans inherited DNA from Neanderthal ancestors is one of the 21st century’s most celebrated discoveries ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...

We once believed the Earth was flat. Nowadays, we're sending crews to space, inventing cures for strange diseases, and ...

Your genetics might play a role in how well cutting-edge weight loss drugs like Ozempic and Zepbound will work for you, a new ...

In a study, people with gene variants in two genes lost slightly more weight on GLP-1 drugs, but threw up more on Zepbound.

Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a ...

Many Americans are turning to artificial intelligence tools such as ChatGPT for health advice. A Gallup poll out Wednesday ...